Cargando…

T-replete HLA-matched grafts vs T-depleted HLA-mismatched grafts in inborn errors of immunity

Hematopoietic cell transplantation (HCT) has become standard-of-care for an increasing number of inborn errors of immunity (IEI). This report is the first to compare transplant outcomes according to T-cell–replete (ie, T-replete) HLA-matched grafts using alemtuzumab (n = 117) and T-cell–depleted (ie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lum, Su Han, Greener, Sinéad, Perez-Heras, Inigo, Drozdov, Daniel, Payne, Rebecca P., Watson, Helen, Carruthers, Kay, January, Robert, Nademi, Zohreh, Owens, Stephen, Williams, Eleri, Waugh, Sheila, Burton-Fanning, Shirelle, Leahy, Timmothy Ronan, Cant, Andrew, Abinun, Mario, Flood, Terry, Hambleton, Sophie, Gennery, Andrew R., Slatter, Mary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2022
Materias:	Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864655/ https://www.ncbi.nlm.nih.gov/pubmed/34972212 http://dx.doi.org/10.1182/bloodadvances.2020004072

Ejemplares similares

TCRαβ-Depleted Haploidentical Grafts Are a Safe Alternative to HLA-Matched Unrelated Donor Stem Cell Transplants for Infants with Severe Combined Immunodeficiency
por: Tsilifis, Christo, et al.
Publicado: (2022)

Outcome of Hematopoietic Stem Cell Transplantation in patients with Mendelian Susceptibility to Mycobacterial Diseases
por: Radwan, Nesrine, et al.
Publicado: (2021)

Haploidentical CD3(+) TCR αβ/CD19(+)–depleted HSCT for MHC class II deficiency and persistent SARS-CoV-2 pneumonitis
por: Ramanathan, Subramaniam, et al.
Publicado: (2022)

Low-Dose Serotherapy Improves Early Immune Reconstitution after Cord Blood Transplantation for Primary Immunodeficiencies
por: Lane, Jonathan P., et al.
Publicado: (2014)

Hematopoietic Cell Transplantation for Adenosine Deaminase Severe Combined Immunodeficiency—Improved Outcomes in the Modern Era
por: Ghimenton, Elisabetta, et al.
Publicado: (2022)

Gut immune reconstitution in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome after hematopoietic stem cell transplantation
por: Gambineri, Eleonora, et al.
Publicado: (2015)

Treosulfan-based conditioning for inborn errors of immunity
por: Slatter, Mary A., et al.
Publicado: (2021)

How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?
por: Chang, Ying-Jun, et al.
Publicado: (2016)

T-Cell Epitopes Shared Between Immunizing HLA and Donor HLA Associate With Graft Failure After Kidney Transplantation
por: Peereboom, Emma T. M., et al.
Publicado: (2021)

HLA and KIR genotyping correlates with relapse after T-cell-replete haploidentical transplantation in chronic myeloid leukaemia patients
por: Zhao, X-Y, et al.
Publicado: (2014)

Hematopoietic Stem Cell Transplantation Resolves the Immune Deficit Associated with STAT3-Dominant-Negative Hyper-IgE Syndrome
por: Harrison, Stephanie C., et al.
Publicado: (2021)

EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity
por: Lankester, A. C., et al.
Publicado: (2021)

Atopic manifestations of inborn errors of immunity
por: Sams, Laura, et al.
Publicado: (2023)

HLA discrepancy between graft and host rather than that graft and first donor impact the second transplant outcome
por: Maeda, Yoshinobu, et al.
Publicado: (2019)

Human herpesvirus-6 viraemia in children with primary immunodeficiency undergoing stem-cell-transplantation
por: Taha, Y., et al.
Publicado: (2006)

Myeloablative Conditioning with PBSC Grafts for T Cell-Replete Haploidentical Donor Transplantation Using Posttransplant Cyclophosphamide
por: Solomon, Scott R., et al.
Publicado: (2016)

Recent advances in graft-versus-host disease
por: Flinn, Aisling M, et al.
Publicado: (2023)

Pre-transplant HLA Antibodies and Delayed Graft Function in the Current Era of Kidney Transplantation
por: Morath, Christian, et al.
Publicado: (2020)

Strategies to Overcome HLA Sensitization and Improve Access to Retransplantation after Kidney Graft Loss
por: Leal, Rita, et al.
Publicado: (2022)

Immune reconstitution after T-cell replete HLA haploidentical hematopoietic stem cell transplantation using high-dose post-transplant cyclophosphamide
por: Maeda, Yoshinobu
Publicado: (2021)

Association of non-HLA antibodies against endothelial targets and donor-specific HLA antibodies with antibody-mediated rejection and graft function in pediatric kidney transplant recipients
por: Fichtner, Alexander, et al.
Publicado: (2021)

Improved kidney graft survival in Eurotransplant by HLA-DR matching and prospectively given blood transfusions.
por: Persijn, G. G., et al.
Publicado: (1981)

Donor Specific Anti-HLA Antibody and Risk of Graft Failure in Haploidentical Stem Cell Transplantation
por: Kongtim, Piyanuch, et al.
Publicado: (2016)

Nonimmunologic Donor-Recipient Pairing, HLA Matching, and Graft Loss in Deceased Donor Kidney Transplantation
por: Vinson, Amanda Jean, et al.
Publicado: (2018)

The Impact of Withdrawal of Maintenance Immunosuppression and Graft Nephrectomy on HLA Sensitization and Calculated Chance of Future Transplant
por: Nimmo, Ailish M. S. A., et al.
Publicado: (2018)

Phosphorylation of S6RP in peritubular capillaries of kidney grafts and circulating HLA donor-specific antibodies
por: Raïch-Regué, Dalia, et al.
Publicado: (2022)

Identification of Heterozygous Single- and Multi-exon Deletions in IL7R by Whole Exome Sequencing
por: Engelhardt, Karin R., et al.
Publicado: (2016)

Investigation of KIR/HLA relationship and other clinical variables after T-cell-replete haploidentical bone marrow transplantation in patients with acute myeloid leukemia (AML)
por: Bakhtiari, Tahereh, et al.
Publicado: (2023)

Proposed Therapeutic Range of Treosulfan in Reduced Toxicity Pediatric Allogeneic Hematopoietic Stem Cell Transplant Conditioning: Results From a Prospective Trial
por: Chiesa, Robert, et al.
Publicado: (2019)

RNA2HLA: HLA-based quality control of RNA-seq datasets
por: Chelysheva, Irina, et al.
Publicado: (2021)

Anti-HLA and Anti-MICA Antibodies in Liver Transplant Recipients: Effect on Long-Term Graft Survival
por: Ciszek, Michał, et al.
Publicado: (2013)

Donor–specific HLA-DQ antibodies may contribute to poor graft outcome after heart transplantation
por: Omrani, Osama, et al.
Publicado: (2018)

Xenogeneic Graft-Versus-Host Disease in Humanized NSG and NSG-HLA-A2/HHD Mice
por: Ehx, Grégory, et al.
Publicado: (2018)

Effect of Preformed or De Novo Anti-HLA Antibodies on Function and Graft Survival in Kidney Transplant Recipients
por: de Sousa, Marcos Vinicius, et al.
Publicado: (2018)

Pretransplant Donor-Specific Anti-HLA Antibodies and the Risk for Rejection-Related Graft Failure of Kidney Allografts
por: Betjes, Michiel G. H., et al.
Publicado: (2020)

Hematopoietic stem cell transplantation for thalassemia major using HLA fully-matched and mismatched donor grafts
por: Huang, Chuwen, et al.
Publicado: (2021)

Fine-tuning alloreactivity against HLA-DP to control leukemia with tolerable graft-versus-host disease
por: Pidala, Joseph, et al.
Publicado: (2022)

Molecular HLA mismatching for prediction of primary humoral alloimmunity and graft function deterioration in paediatric kidney transplantation
por: Kim, Jon Jin, et al.
Publicado: (2023)

Personalized hematopoietic stem cell transplantation for inborn errors of immunity
por: Slatter, Mary, et al.
Publicado: (2023)

Treatment of Pediatric Acute Graft-versus-Host Disease—Lessons from Primary Immunodeficiency?
por: Flinn, Aisling M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_h1eik2s1oeh874fr5dpdcoc3fq